PT2139917T - Péptidos antiandrogénio e utilizações dos mesmos em terapia de cancro - Google Patents

Péptidos antiandrogénio e utilizações dos mesmos em terapia de cancro

Info

Publication number
PT2139917T
PT2139917T PT87178661T PT08717866T PT2139917T PT 2139917 T PT2139917 T PT 2139917T PT 87178661 T PT87178661 T PT 87178661T PT 08717866 T PT08717866 T PT 08717866T PT 2139917 T PT2139917 T PT 2139917T
Authority
PT
Portugal
Prior art keywords
cancer therapy
androgen
peptides
androgen peptides
cancer
Prior art date
Application number
PT87178661T
Other languages
English (en)
Portuguese (pt)
Inventor
Auricchio Ferdinando
Migliaccio Antimo
Original Assignee
Cancer Research Tech Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=39766539&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PT2139917(T) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Cancer Research Tech Ltd filed Critical Cancer Research Tech Ltd
Publication of PT2139917T publication Critical patent/PT2139917T/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/10—Peptides having 12 to 20 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/08—Drugs for disorders of the urinary system of the prostate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/72—Receptors; Cell surface antigens; Cell surface determinants for hormones
    • C07K14/721—Steroid/thyroid hormone superfamily, e.g. GR, EcR, androgen receptor, oestrogen receptor
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Endocrinology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Cell Biology (AREA)
  • Reproductive Health (AREA)
  • Urology & Nephrology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
PT87178661T 2007-03-16 2008-03-14 Péptidos antiandrogénio e utilizações dos mesmos em terapia de cancro PT2139917T (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US89542407P 2007-03-16 2007-03-16

Publications (1)

Publication Number Publication Date
PT2139917T true PT2139917T (pt) 2018-07-18

Family

ID=39766539

Family Applications (1)

Application Number Title Priority Date Filing Date
PT87178661T PT2139917T (pt) 2007-03-16 2008-03-14 Péptidos antiandrogénio e utilizações dos mesmos em terapia de cancro

Country Status (15)

Country Link
US (3) US20100189776A1 (enExample)
EP (2) EP2139917B1 (enExample)
JP (4) JP5464344B2 (enExample)
AU (1) AU2008228274B2 (enExample)
CY (1) CY1120436T1 (enExample)
DK (1) DK2139917T3 (enExample)
ES (1) ES2677566T3 (enExample)
HR (1) HRP20181178T1 (enExample)
HU (1) HUE039249T2 (enExample)
LT (1) LT2139917T (enExample)
PL (1) PL2139917T3 (enExample)
PT (1) PT2139917T (enExample)
SI (1) SI2139917T1 (enExample)
TR (1) TR201809422T4 (enExample)
WO (1) WO2008113770A2 (enExample)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20100189776A1 (en) 2007-03-16 2010-07-29 Cancer Research Technology Ltd Anti-androgen peptides and uses thereof in cancer therapy
GB2496135B (en) * 2011-11-01 2015-03-18 Valirx Plc Inhibitors of the interaction between a Src family kinase and an androgen receptor or estradiol receptor for treatment of endometriosis
GB2513615A (en) * 2013-05-01 2014-11-05 Cancer Rec Tech Ltd Medical use
JPWO2014188775A1 (ja) * 2013-05-23 2017-02-23 国立大学法人東北大学 アンドロゲンレセプター活性依存性乳癌細胞株の作製方法、当該細胞株を用いたスクリーニング方法、ならびに乳癌患者におけるアンドロゲンレセプター活性依存性獲得の判定方法、キット及びマーカー
KR102417496B1 (ko) * 2019-11-29 2022-07-06 (주)수파드엘릭사 안드로겐 수용체의 활성을 억제하는 폡타이드 및 이를 이용하는 화장료 조성물
US20230226138A1 (en) 2020-06-01 2023-07-20 Black Cat Bio Limited Compositions and methods for treating infections and netopathy
IL314615A (en) * 2022-02-04 2024-09-01 Hbc Immunology Inc Medical uses of oligopeptides in combination with antiandrogen

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1005357A1 (en) * 1997-04-14 2000-06-07 The Regents Of The University Of California Peptide antiestrogen compositions and methods for treating breast cancer
AU4494399A (en) 1998-06-30 2000-01-24 University Of British Columbia, The Inhibitors of androgen-independent activation of androgen receptor
DK1379550T3 (da) * 2000-12-21 2009-07-06 Us Gov Health & Human Serv Et kimært protein omfattende non-toxisk pseudomonas exotoxin A og en type IV pilin sekvenser
CA2446819A1 (en) * 2001-05-08 2002-11-14 Merck & Co., Inc. Dna molecules encoding macaca mulatta androgen receptor
WO2005017179A2 (en) * 2003-05-30 2005-02-24 New York University Antibodies that recognize and bind phosphorylated human androgen receptor and methods of using same
WO2007041497A2 (en) * 2005-09-30 2007-04-12 Cleveland Biolabs, Inc. Modulation of androgen receptor
US20100189776A1 (en) 2007-03-16 2010-07-29 Cancer Research Technology Ltd Anti-androgen peptides and uses thereof in cancer therapy

Also Published As

Publication number Publication date
JP2014087363A (ja) 2014-05-15
JP2019150029A (ja) 2019-09-12
TR201809422T4 (tr) 2018-07-23
JP2016175927A (ja) 2016-10-06
EP2139917B1 (en) 2018-04-25
US9919023B2 (en) 2018-03-20
SI2139917T1 (sl) 2018-10-30
JP6689430B2 (ja) 2020-04-28
PL2139917T3 (pl) 2018-09-28
EP3412685A1 (en) 2018-12-12
JP2010521441A (ja) 2010-06-24
HRP20181178T1 (hr) 2018-12-14
HUE039249T2 (hu) 2018-12-28
WO2008113770A3 (en) 2009-02-12
AU2008228274A1 (en) 2008-09-25
JP6545122B2 (ja) 2019-07-17
WO2008113770A2 (en) 2008-09-25
US20180271933A1 (en) 2018-09-27
DK2139917T3 (en) 2018-07-23
JP5998161B2 (ja) 2016-09-28
AU2008228274B2 (en) 2013-04-18
CY1120436T1 (el) 2019-07-10
LT2139917T (lt) 2018-07-10
US20100189776A1 (en) 2010-07-29
US20150202249A1 (en) 2015-07-23
ES2677566T3 (es) 2018-08-03
JP5464344B2 (ja) 2014-04-09
US11560406B2 (en) 2023-01-24
EP2139917A2 (en) 2010-01-06

Similar Documents

Publication Publication Date Title
ZA201104497B (en) Peptide therapeutic conjugates and uses thereof
GB0702020D0 (en) Peptides and their use
EP2038041A4 (en) THERAPEUTIC COMPOUNDS AND THEIR USE AGAINST CANCER
GB0712670D0 (en) Isolated peptides and uses thereof
GB0823091D0 (en) Exfoliating vermiculite and other minerals
WO2010096603A3 (en) Cancer-targeting peptides and uses thereof in cancer therapy
IL199041A (en) We nanoparticle peptides and their uses
HUE037109T2 (hu) Endoxifén rák kezelésében történõ alkalmazásra
GB0702021D0 (en) Peptides and their use
GB0702022D0 (en) Peptides and their use
LT2139917T (lt) Antiandrogeniniai peptidai ir jų naudojimas vėžio terapijai
GB2460181B (en) Depsipeptides and their therapeutic use
GB2460178B (en) Depsipeptides and their therapeutic use
PL2222692T3 (pl) Syntetyczny peptyd wiążący się z ludzkim CD154 i jego zastosowania
GB0701728D0 (en) Assays and therapy
SG10201506725QA (en) Sdf-1 binding nucleic acids and the use thereof in cancer treatment
GB2460180B (en) Depsipeptides and their therapeutic use
GB0722399D0 (en) MHC binding peptides and their uses
EP2234667A4 (en) DETERMINATION AND METHODS OF ADMINISTERING A TREATMENT
GB0724934D0 (en) A protein involved in cancer
GB0814920D0 (en) Peptides and their use in treatment
GB0710813D0 (en) Peptides and uses thereof
GB0819103D0 (en) Raphaine compounds and their use in therapy
GB0702003D0 (en) Improvements in relation to cancer therapy
GB0800502D0 (en) Peptides and their uses